Ph: 10342599
Your browser version may not work well with NCBI's Web applications. More information here...
1: J Child Neurol. 1999 May;14(5):316-9.Links
Comment in:
J Child Neurol. 2000 Sep;15(9):631-4.

Tics in Tourette syndrome: new treatment options.

Children's Hospital of Michigan, Movement Disorder Clinic, Wayne State University, School of Medicine, Detroit 48201, USA. yawaad@med.wayne.edu

Tourette Syndrome is a familial neurobehavioral disorder characterized by fluctuating involuntary motor and/or vocal tics. The most commonly used medications to treat Tourette's syndrome are haloperidol, pimozide, fluphenazine, and clonidine, all of which may have considerable side effects. We enrolled 450 patients with tics/Tourette's syndrome to be treated with baclofen/botolinum toxin type A for their symptoms. Global severity of tic symptoms was rated by the Yale Global Tic Severity Scale and a quantified videotaped micro-structured analysis of tics. We found that baclofen/botolinum toxin type A are very effective, safe, and reliable in the treatment of tics/Tourette's syndrome. It is worthwhile considering this treatment approach in patients with tics/Tourette's syndrome in order to reduce or avoid the side effects of other medications. Further studies, however, are required.

PMID: 10342599 [PubMed - indexed for MEDLINE]


You are viewing a mobilized version of this site...
View original page here

How do you rate mobile version of this page?

Mobilized by Mowser Mowser